Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `News and Events` |u:www.enterprize.cam.ac.uk.  Search for `News and Events` |u:www.enterprise.cam.ac.uk instead.
31 - 50 of 62 search results for `News and Events` |u:www.enterprise.cam.ac.uk or `News and Events` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Fluidity One system Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/fluidity-one-system/feed/
    25 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"
  3. ‘Mid-sized’ firms key to UK manufacturing and economy – Cambridge…

    https://www.enterprise.cam.ac.uk/news/mid-sized-firms-key-to-uk-manufacturing/
    Thumbnail for ‘Mid-sized’ firms key to UK manufacturing and economy – Cambridge Enterprise 23 Oct 2020: Society for the encouragement of Arts, Manufactures and Commerce (RSA) and supported by Lloyds banking group. ... France – and continue the spiral of decline we are currently seeing in UK manufacturing.
  4. University of Cambridge Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/university-of-cambridge/feed/
    25 Jul 2024: cam.ac.uk/news/lab-grown-mini-guts-could-help-in-development-of-new-and-more-personalised-treatments-for-crohns-disease/ Gianluca D'Uva Tue, 11 Jun 2024 16:20:20 ... 342px) 100vw, 342px" //a/div /div /blockquote /div pRead the full release a href="https:/
  5. Sentinel Oncology awarded Eurostars grant for research and

    https://www.enterprise.cam.ac.uk/news/sentinel-oncology-awarded-eurostars-grant-for-rd/
    Thumbnail for Sentinel Oncology awarded Eurostars grant for research and development – Cambridge Enterprise 23 Oct 2020: Current drug treatments for AML suffer from poor efficacy and numerous unwanted side-effects. ... The Eurostars programme was established to assist small and medium enterprises (SMEs) in obtaining research and development funding.
  6. protein social network Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/protein-social-network/feed/
    25 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"
  7. Cambridge and Nanjing launch strategic collaboration – Cambridge…

    https://www.enterprise.cam.ac.uk/news/cambridge-and-nanjing-launch-strategic-collaboration/
    Thumbnail for Cambridge and Nanjing launch strategic collaboration – Cambridge Enterprise 23 Oct 2020: As well as supporting health and wellbeing in new cities, the new Centre will help deliver efficient energy use through its academic and entrepreneurial activities. ... The Vice-Chancellor was joined by Professor Sir Mark Welland, Head of the
  8. Annual awards recognise Cambridge innovation and excellence –…

    https://www.enterprise.cam.ac.uk/news/annual-awards-recognise-cambridge-innovation-and-excellence/
    Thumbnail for Annual awards recognise Cambridge innovation and excellence – Cambridge Enterprise 23 Feb 2023: million Series A Funding with Medicxi and Johnson & Johnson Innovation to develop antibodies with anticoagulant properties. ... into the discovery of first-in-class drugs in oncology and other diseases.
  9. Academy award for founder and CEO of Cambridge spin-out – Cambridge…

    https://www.enterprise.cam.ac.uk/news/academy-award-for-founder-and-ceo-of-cambridge-spin-out/
    Thumbnail for Academy award for founder and CEO of Cambridge spin-out – Cambridge Enterprise 22 Feb 2023: 10 July 2019. Academy award for founder and CEO of Cambridge spin-out. ... in applications ranging from power supplies for consumer electronics to LED drives, data centres and wireless chargers.
  10. A look at golden shares and anti-dilution provisions – Cambridge…

    https://www.enterprise.cam.ac.uk/news/a-look-at-golden-shares-and-anti-dilution-provisions/
    Thumbnail for A look at golden shares and anti-dilution provisions – Cambridge Enterprise 23 Oct 2020: Hockaday, CEO, Isis Innovation ltd and Tony Hickson, Managing Director Technology Transfer, Imperial Innovations plc. ... that UK universities take too much equity in spin-outs and more equity should be retained by founding entrepreneurs to incentivise
  11. Spin-out Morphogen-IX announces appointment of CEO and SAB members –…

    https://www.enterprise.cam.ac.uk/news/spin-morphogen-ix-announces-appointment-ceo-sab-members/
    Thumbnail for Spin-out Morphogen-IX announces appointment of CEO and SAB members – Cambridge Enterprise 23 Oct 2020: 28 June 2018. Spin-out Morphogen-IX announces appointment of CEO and SAB members. ... The SAB comprises leading international experts in the field of PAH research, experimental medicine and clinical trials:.
  12. Biomarker signature identified for Crohn's and ulcerative colitis …

    https://www.enterprise.cam.ac.uk/news/biomarker-signature-identified-for-crohns-and-ulcerative-colitis/
    Thumbnail for Biomarker signature identified for Crohn's and ulcerative colitis – Cambridge Enterprise 23 Oct 2020: Share:. Crohn’s disease and ulcerative colitis are increasingly common, chronic forms of inflammatory bowel disease which predominantly affect young adults. ... Cambridge Enterprise, the University’s commercialisation group, is seeking a commercial
  13. Cambridge Graphene Centre and Plastic Logic announce partnership –…

    https://www.enterprise.cam.ac.uk/news/cambridge-graphene-centre-and-plastic-logic-announce-partnership/
    Thumbnail for Cambridge Graphene Centre and Plastic Logic announce partnership – Cambridge Enterprise 23 Oct 2020: Share:. A formal collaboration between Cambridge’s Graphene Centre, and the University spin-out company, Plastic Logic, has been announced. ... The research of the Centre aims to find ways of manufacturing and optimising graphene and related materials
  14. GeoSpock captures space and time to deliver database for IoT –…

    https://www.enterprise.cam.ac.uk/news/geospock-captures-space-and-time-to-deliver-database-for-iot/
    Thumbnail for GeoSpock captures space and time to deliver database for IoT – Cambridge Enterprise 23 Oct 2020: 16 November 2015. GeoSpock captures space and time to deliver database for IoT. ... A new generation of applications use time and place to deliver a customer service.
  15. Overnight home use of artificial pancreas ‘feasible and beneficial’ – …

    https://www.enterprise.cam.ac.uk/news/overnight-home-use-of-artificial-pancreas-feasible-and-beneficial/
    Thumbnail for Overnight home use of artificial pancreas ‘feasible and beneficial’ – Cambridge Enterprise 23 Oct 2020: The success of this trial means that larger and longer studies are already in the pipeline. ... The findings from this study are positive and are certainly worth investigating further.
  16. Spin-out PredictImmune announces new patent grants and allowances in…

    https://www.enterprise.cam.ac.uk/news/spin-predictimmune-announces-new-patent-grants-allowances-uk-eu-canada/
    Thumbnail for Spin-out PredictImmune announces new patent grants and allowances in UK, EU, Canada – Cambridge Enterprise 22 Feb 2023: 18 October 2018. Spin-out PredictImmune announces new patent grants and allowances in UK, EU, Canada. ... and immune mediated diseases, including ANCA-Associated Vasculitis (AAV) and Inflammatory Bowel Disease (IBD).
  17. Enterprise Tuesday: investment and understanding funding methods –…

    https://www.enterprise.cam.ac.uk/news/enterprise-tuesday-getting-investment-and-understanding-funding-methods/
    Thumbnail for Enterprise Tuesday: investment and understanding funding methods – Cambridge Enterprise 23 Oct 2020: She then moved to the US where she spearheaded multimedia productions for Intuit, The Learning Company and Standard&Poors. ... This evening’s lecture begins at 6pm and takes place in Lecture Theatre 0 at the Department of Engineering.
  18. Horizon Discovery and Eight19 winners at Business Weekly awards –…

    https://www.enterprise.cam.ac.uk/news/horizon-discovery-and-eight19-among-winners-at-business-weekly-awards/
    Thumbnail for Horizon Discovery and Eight19 winners at Business Weekly awards – Cambridge Enterprise 23 Oct 2020: The Business of the Year was chosen from all the final shortlisted companies and recognised a company which made the largest strides in 2011. ... lighting. By combining solar and mobile phone technology, Eight19 is bringing electricity directly to
  19. Spin-out Sano Genetics raises £2.5m – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-sano-genetics-raises-2-5m-and-accelerates-research-into-long-covid/
    Thumbnail for Spin-out Sano Genetics raises £2.5m – Cambridge Enterprise 23 Feb 2023: 29 January 2021. Cambridge spin-out Sano Genetics raises £2.5m and accelerates research into long COVID. ... changing medicines and, in doing so, improve the outlook for people living with chronic and often debilitating conditions.
  20. New treatments for pain and MS being developed in open innovation…

    https://www.enterprise.cam.ac.uk/news/new-treatments-for-pain-and-ms-being-developed-in-open-innovation-programme/
    Thumbnail for New treatments for pain and MS being developed in open innovation programme – Cambridge Enterprise 23 Oct 2020: 25 June 2013. New treatments for pain and MS being developed in open innovation programme. ... Stevenage Bioscience Catalyst is a strong model for the future of university and industry collaboration.”.
  21. PhoreMost and The Wistar Institute collaborate to identify new…

    https://www.enterprise.cam.ac.uk/news/phoremost-and-the-wistar-institute-collaborate-to-identify-new-druggable-targets/
    Thumbnail for PhoreMost and The Wistar Institute collaborate to identify new druggable targets – Cambridge Enterprise 23 Oct 2020: 10 March 2016. PhoreMost and The Wistar Institute collaborate to identify new druggable targets. ... identify and de-orphan novel targets in cancer, ageing and the immune system.

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.